TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Fourth Quarter and Year Ended 2022 Earnings Conference Call. .
Tracon Pharmaceuticals Inc. (TCON)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 4,590,000 | $6,839,100 | +10% | 2.37% |
| 2. | Ikarian Capital Neil Shahrestani | 2,765,530 | $4,120,639 | 0.99% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 53,200 | $79,268 | -48% | 0% |
| 4. | 41,500 | $61,835 | +44% | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 1,592 | $2,372 | -93% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.38 | 174,508 | Large Shareholder | 4,324,508 | 2023-03-09 | Filing | |
| $1.52 | 4,800 | Officer, Director | 344,918 | 2023-03-01 | Filing | |
| $1.52 | 200 | Officer, Director | 340,118 | 2023-02-28 | Filing | |
| $1.62 | 6,800 | Officer, Director | 339,918 | 2023-01-18 | Filing | |
| $1.49 | 3,500 | Officer | 21,628 | 2022-12-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.26 | 120 | Director | 7,763 | 2022-12-21 | Filing | |
| $1.44 | 1,539 | Large Shareholder | 4,010,000 | 2022-12-06 | Filing | |
| $2.92 | 340,134 | Large Shareholder | 76,048 | 2019-12-09 | Filing | |
| $3.05 | 43,996 | Large Shareholder | 416,182 | 2019-12-05 | Filing | |
| $1.21 | 4,326 | Large Shareholder | 4,601,768 | 2018-11-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 591,020 | $880,619 | 0% | |
| 2. | 454,916 | $677,825 | 0% | |
| 3. | 307,954 | $458,852 | 0% | |
| 4. | 258,844 | $385,678 | 0% | |
| 5. | 75,154 | $111,979 | 0% |
News See All
5 Penny Stocks with Upcoming Growth Catalysts
In this article, we discuss the 5 penny stocks with upcoming growth catalysts.
5 Stocks to Buy According to Neil Shahrestani's Ikarian Capital
In this article, we will discuss the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.
Is TRACON Pharmaceuticals Inc (TCON) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is TRACON Pharmaceuticals (TCON) A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Should You Buy TRACON Pharmaceuticals Inc (TCON)?
In this article we will take a look at whether hedge funds think TRACON Pharmaceuticals Inc (NASDAQ:TCON) is a good investment right now.
Should You Buy TRACON Pharmaceuticals Inc (NASDAQ:TCON)?
With the first-quarter round of 13F filings behind us, it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second...
Hedge Fund and Insider Trading News: Andrew Feldstein, Anthony Scaramucci, Och-Ziff Capital Management, Elliott Management, Arrow Financial Corporation (AROW), Chemed Corporation (CHE), and More
In naming their hedge funds, managers have found inspiration in a childhood neighborhood (Highbridge), favorite ski trails (FrontFour) and even a grandfather (Melvin).
Hedge Fund and Insider Trading News: Eddie Lampert, Steve Cohen, Scientific Games Corp (SGMS), TRACON Pharmaceuticals Inc (TCON), AllianceBernstein Holding LP (AB), and More
Back in November, billionaire Steve Cohen predicted a bear market was approaching. The time frame he gave during an interview with the Financial Times (FT) was for it to come in 18 months.
13G Filing: 683 Capital Partners and Tracon Pharmaceuticals Inc. (TCON)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
Billionaire Hedge Funds
